Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0494
-0.0006 (-1.28%)
At close: Nov 6, 2025
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $2.07 million as of November 7, 2025. Its market cap has decreased by -94.93% in one year.
Market Cap
2.07M
Enterprise Value
1.77M
Revenue
10.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 2.07M, a decrease of -98.60%. That is a compound annual growth rate of -79.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.07M | -88.19% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.15M |
| Elite Pharmaceuticals | 645.15M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 360.12M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 304.66M |